Irina Blumenstein

Goethe University Frankfurt — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index1.4kcitations127works1.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(71), Microscopic Colitis(39), Eosinophilic Esophagitis(29), Clinical Nutrition and Gastroenterology(9), Immunodeficiency and Autoimmune Disorders(9)

Publications127 total

Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age
Inflammatory Bowel Diseases·2025Open Access
Interferon Regulator Factor 5: A Novel Inflammatory Marker and Promising Therapeutic Target in Ulcerative Colitis
Biomedicines·2025Open Access
Sustained corticosteroid-sparing effects of upadacitinib maintenance therapy in patients with moderate-to-severe crohn’s disease: 2-year results from the U-ENDURE long-term extension study
Zeitschrift für Gastroenterologie·2025
Hybride Versorgungsmodelle in der gastroenterologischen ambulanten Versorgung: Ergebnisse aus einem deutschen Universitätsklinikum
Zeitschrift für Gastroenterologie·2025
Retrospektive monozentrische Analyse von PICC-Lines (peripherally inserted central catheter) zur Entwicklung einer Formel zur Bestimmung der idealen PICC-Länge
Zeitschrift für Gastroenterologie·2025
Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn’s disease: 2-year results from the U-ENDURE Long-Term Extension study
Journal of Crohn s and Colitis·2025· 2 citedOpen Access
P265 Efficacy and safety of the mirikizumab extended induction cohort moderately-to-severely active ulcerative colitis: LUCENT-3 open-label extension study results
2025
P31 Improvement in health-related quality of life in moderate to severe Crohn’s disease patients treated with risankizumab versus ustekinumab: SEQUENCE study
2025
Tu1835: EFFICACY AND SAFETY OF THE MIRIKIZUMAB EXTENDED INDUCTION COHORT AT 152 WEEKS OF CONTINUOUS TREATMENT FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE LUCENT-3 OPEN-LABEL EXTENSION STUDY
Gastroenterology·2025
Telemedicine Hybrid Care Models in Gastroenterology Outpatient Care: Results from a German Tertiary Center
Journal of Clinical Medicine·2025· 3 citedOpen Access
S3-Leitlinie Klinische Ernährung bei chronisch-entzündlichen Darmerkrankungen
Aktuelle Ernährungsmedizin·2025· 3 cited
Neue und aktuelle Therapieziele bei chronisch entzündlichen Darmerkrankungen
DMW - Deutsche Medizinische Wochenschrift·2025
Comparative real-world effectiveness of ustekinumab versus anti-TNF in Crohn’s disease: 12-month maintenance phase results from the prospective, observational RUN-CD study using propensity score adjustment
Journal of Crohn s and Colitis·2025· 2 cited
Neue Therapien zur Behandlung der chronisch entzündlichen Darmerkrankungen – ein Update
Verdauungskrankheiten·2025
Antwort
Zeitschrift für Gastroenterologie·2025
P0965 Sequencing Therapy for Optimal Response in Mirikizumab (STORM) Study
Journal of Crohn s and Colitis·2025
S1472 Efficacy of Risankizumab Maintenance Therapy by Clinical Remission and Endoscopic Improvement Status in Patients With Moderately to Severely Active Ulcerative Colitis: Post Hoc Analysis of the COMMAND Phase 3 Study
The American Journal of Gastroenterology·2024
S1050 Efficacy and Safety of Upadacitinib Maintenance Treatment in Patients With Moderately to Severely Active Crohn’s Disease: Two Year Results From the U-ENDURE Long-Term Extension Study
The American Journal of Gastroenterology·2024
Framework of IBD Care Delivery Across Ages
Journal of Crohn s and Colitis·2024· 7 citedOpen Access
S1448 Impact of Prior Biologic Exposure on the Durability of Ozanimod Over 5 Years of Continuous Treatment in Patients With Ulcerative Colitis: An Interim Analysis of the True North Open-Label Extension Study
The American Journal of Gastroenterology·2024
page 1 of 7Next →

Frequent Co-authors

Natalie Filmann(11), Stefan Zeuzem(10), Alica Kubesch(10), Johannes Hausmann(9), Oliver Schröder(8), Axel Dignaß(8), Jürgen M. Stein(7), W Tacke(6), Eva Herrmann(5), Andreas Sturm(5), Katharina Stratmann(5), Thomas Krause(4), Andreas Stallmach(4), Torsten Kucharzik(4), Ulf Helwig(4), Petra Lynen(4), Carsten Schmidt(4), C. Zosel(3), H. Böck(3), Kathrin Sprinzl(3)